LOGIN
AAOS 2016: TXA improves clinical and surgical outcomes after foot and ankle surgery
March 2016
AAOS 2016: TXA improves clinical and surgical outcomes after foot and ankle surgery
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Tranexamic Acid Reduces Postoperative Morbidity in Patients Undergoing Foot and Ankle Surgery
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
100 patients undergoing foot and ankle surgery were randomized to either administration of tranexamic acid (TXA), or a control group without TXA administration. The purpose of this study was to determine whether the use of TXA was associated with reductions in perioperative morbidity in foot and ankle procedures. Findings indicated significantly decreased ecchymosis, edema, erythema, and bleeding ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.